Wordt geladen...
ADHD Medication Use Following FDA Risk Warnings
BACKGROUND: In 2006, the U.S. Food and Drug Administration (FDA) investigated cardiac and psychiatric risks associated with attention deficit/hyperactivity disorder (ADHD) medication use. AIMS OF THE STUDY: To examine how disclosure of safety risks affected pediatric ADHD use, and to assess news med...
Bewaard in:
| Hoofdauteurs: | , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2012
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3896970/ https://ncbi.nlm.nih.gov/pubmed/23001280 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|